88 related articles for article (PubMed ID: 7198291)
1. Adenocarcinoma of unknown primary origin: impact of chemotherapy on survival.
Indupalli SR; Bedikian AY; Bodey GP
South Med J; 1981 Dec; 74(12):1431-5. PubMed ID: 7198291
[TBL] [Abstract][Full Text] [Related]
2. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
Britell JC; Eagan RT; Ingle JN; Creagen ET; Rubin J; Frytak S
Cancer Treat Rep; 1978 Aug; 62(8):1207-10. PubMed ID: 688256
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma.
Parker LM; Griffiths CT; Yankee RA; Canellos GP; Gelman R; Knapp RC; Richman CM; Tobias JS; Weiner RS; Frei E
Cancer; 1980 Aug; 46(4):669-74. PubMed ID: 7397632
[TBL] [Abstract][Full Text] [Related]
4. Treatment of an Nb-Pr-A.I.-3 (autonomous) tumor with combination chemotherapy.
Drago JR; Worgul T
Cancer Chemother Pharmacol; 1981; 5(3):163-6. PubMed ID: 7197592
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung.
Edmonson JH; Lagakos SW; Selawry OS; Perlia CP; Bennett JM; Muggia FM; Wampler G; Brodovsky HS; Horton J; Colsky J; Mansour EG; Creech R; Stolbach L; Greenspan EM; Levitt M; Israel L; Ezdinli EZ; Carbone PP
Cancer Treat Rep; 1976 Jul; 60(7):925-32. PubMed ID: 1009523
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.
Hainsworth JD; Johnson DH; Greco FA
J Clin Oncol; 1992 Jun; 10(6):912-22. PubMed ID: 1375284
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
Buzzoni R; Bonadonna G; Valagussa P; Zambetti M
J Clin Oncol; 1991 Dec; 9(12):2134-40. PubMed ID: 1960555
[TBL] [Abstract][Full Text] [Related]
10. Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer.
Coskun U; Gunel N; Onuk E; Yilmaz E; Bayram O; Yamac D; Cihan A; Ucan B; Yildirim Y; Celenkoglu G; Ozkan S
Neoplasma; 2003; 50(3):210-6. PubMed ID: 12937855
[TBL] [Abstract][Full Text] [Related]
11. [Ovarian adenocarcinoma stage III and IV treated by a combination of adriamycin, cyclophosphamide, 5-fluorouracil and cis-DDP. Therapeutic role of cis-DDP in this combination].
Pouillart P; Bretaudeau B; Palangie T; Jouve M; Garcia-Giralt E; Asselain B
Bull Cancer; 1982; 69(5):434-42. PubMed ID: 6891903
[TBL] [Abstract][Full Text] [Related]
12. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
14. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
[TBL] [Abstract][Full Text] [Related]
15. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma.
Hidaka T; Nakamura T; Shima T; Yuki H; Saito S
J Obstet Gynaecol Res; 2006 Jun; 32(3):330-7. PubMed ID: 16764625
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.
Bruckner HW; Ratner LH; Cohen CJ; Wallach R; Kabakow B; Greenspan EM; Holland JF
Cancer Treat Rep; 1978 Jul; 62(7):1021-3. PubMed ID: 688244
[TBL] [Abstract][Full Text] [Related]
18. Single-agent and combination chemotherapy for extensive non-small cell carcinomas of the lung.
Davis S; Pandya MR; Rambotti P
Cancer Treat Rep; 1980; 64(4-5):685-8. PubMed ID: 6253067
[TBL] [Abstract][Full Text] [Related]
19. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin.
Piver MS; Eltabbakh GH; Hempling RE; Recio FO; Blumenson LE
Gynecol Oncol; 1997 Nov; 67(2):141-6. PubMed ID: 9367697
[TBL] [Abstract][Full Text] [Related]
20. A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study.
Thigpen JT; Blessing JA; DiSaia PJ; Yordan E; Carson LF; Evers C
J Clin Oncol; 1994 Jul; 12(7):1408-14. PubMed ID: 8021731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
